Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-28T02:50:58.316Z Has data issue: false hasContentIssue false
  • English
  • Français

The combined use of amiodarone and class 1-C antiarrhythmic agents in children with intractable supraventricular tachyarrhythmias

Published online by Cambridge University Press:  19 August 2008

Seshadri Balaji ,
Christopher L. Case  and
Paul C. Gillette
Seshadri Balaji*
Affiliation:
From the South Carolina Children's Heart Center, Charleston
Christopher L. Case
Affiliation:
From the South Carolina Children's Heart Center, Charleston
Paul C. Gillette
Affiliation:
From the South Carolina Children's Heart Center, Charleston
*
Correspondence to Dr. Seshadri Balaji, Department of Paediatrics, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom. Tel. 44-71 352 8121; Fax. 44-71 351 8547.
Get access Rights & Permissions [Opens in a new window]

Abstract

Combined antiarrhythmic drug therapy is an occasionally necessary but problematic approach to the child with recalcitrant supraventricular tachycardia. There is little experience with the combined use of amiodarone and class 1-C agents (flecainide, propafenone and encainide) in children. To judge the efficacy and safety of this combination, we reviewed the case notes and results of investigation in all nine children with supraventricular tachycardia who received such therapy between 1984 and 1993. These nine children received combined therapy on 12 occasions. Five were infants with either atrioventricular reentrant tachycardia (n=3) or atrial ectopic tachycardia (n=2), and four were older children with atrial flutter seen after a Fontan procedure. Amiodarone was combined with flecainide on eight occasions, with propafenone on three occasions, and with encainide on one occasion. Both infants with atrial ectopic tachycardia were successfully controlled, but only one of three infants with atrioventricular reentrant tachycardia had successful control on combination therapy. In three of the four patients with atrial flutter, the combination was useful in reducing the number of arrhythmic episodes. Three infants suffered side effects. At electrophysiologic study to judge efficacy, ventricular tachycardia was induced in two patients (one infant and one Fontan patient), necessitating a change in the 1-C agent. One patient had skin rash due to flecainide and was placed on propafenone with success. One Fontan patient died of complications after an elective surgical procedure. No deaths occurred attributable to proarrhythmia. Thus, combined therapy with amiodarone and 1-C agents was found to be safe and fairly effective in children with certain types of intractable supraventricular tachycardia.

Keywords

Arrhythmiaantiarrhythmic therapyamiodaroneflecainidepropafenonesupraventricular tachycardia
Type
Original Articles
Information
Cardiology in the Young , Volume 5 , Issue 1 , January 1995 , pp. 70 - 74
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pongliglione, G, Strasburger, JF, Deal, BJ, Benson, W.Use of amiodarone for short-term and adjuvant therapy in young patients. Am J Cardiol 1991; 68: 603–608.CrossRefGoogle Scholar
Case, CL, Gillette, PC, Osliziok, PC, Knick, BJ, Blair, HL.Radio-frequency catheter ablation of incessant, medically resistant supraventricular tachycardia in infants and small chiidren.J Am Coll Cardiol 1992; 20: 1405–1410.Google Scholar
Shuler, CO, Case, CL, Gillette, PC.Efficacy and safety of amiodarone in infants. Am Heart J 1993; 125: 1430–1432.CrossRefGoogle ScholarPubMed
Garson, A Jr, Gillette, PC, McVey, P, Hesslein, PS, Porter, CJ, Hittner, HM, Angell, LK, Kaldis, LC.Amiodarone treatment of critical dysrhythmias in children and young adults. J Am Coll Cardiol 1984; 4: 749–755.CrossRefGoogle ScholarPubMed
Perry, JC, McQuinn, RL, Smith, RT, Gothing, C, Fredell, P, Garson, A JrFlecainide acetate for resistant arrhythmias in the young: Efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14: 185–191.Google Scholar
Zeigler, V, Gillette, PC, Hamill, W, Ross, BA, Ewing, LE..Flecainide for supraventricular tachycardia in children. Am J Cardiol 1988; 62: 410–413.Google Scholar
Guccione, P, Drago, F, Di Donato, RM, Cicini, MP, Pasquini, L, Marino, B, Marcelletti, C, Ragonese, P..Oral propafenone therapy for children with arrhythmias: Efficacy and adverse effects in midterm follow-up. Am Heart J 1991; 122: 1022–1027.CrossRefGoogle ScholarPubMed
Podrid, PJ..Aggravation of arrhythmia: a complication of antiarrhythmic drugs. J Cardiovasc Electrophysiol 1993; 4:311–319.Google Scholar
Levy, S..Combination therapy for cardiac arrhythmias. Am J Cardiol 1988; 61: 95A–101A.CrossRefGoogle ScholarPubMed
Toivonen, L, Kadish, A, Morady, F.A prospective comparison of Class 1-A, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Circulation 1991; 84: 101–108.Google Scholar
Fish, FA, Gillette, PC, Benson, DW Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide.J Am Coll Cardiol 1991; 18: 356–365.Google Scholar
Case, CL, Trippel, DL, Gillette, PC..New antiarrhyrhmic agents in pediatrics. Pediatr Clin North Am 1989; 36: 1293–1320.CrossRefGoogle ScholarPubMed
Fenrich, AL Jr, Friedman, RA, Perry, JC.Flecainide and amiodarone: combined therapy for refractory tachyarrhyrhmias in infancy. Am J Cardiol 1993; 72: 506. [Abstract]CrossRefGoogle Scholar
Case, CL, Gillette, PC, Crawford, FA..Cardiac rhabdomyomas causing supraventricular and lethal ventricular arrhythmias in an infant. Am Heart J 1991; 122: 1484–1486.CrossRefGoogle ScholarPubMed
Erikson, C, Perry, J, Marlow, D, Garson, A Jr. Sudden death during propafenone therapy for atrial flutter in young post-operative heart patients. Pace 1993; 16: 939. [Abstract]Google Scholar
Case, CL, Gillette, PC, Zeigler, V, Sade, RM.Problems with permanent atrial pacing in the Fontan patient. Pace 1989; 12:92–96.CrossRefGoogle ScholarPubMed
Garson, A Jr, Bink-Boelkens, M, Hesslein, PS, Hordof, AJ,Keane, JF, Neches, WH, Porter, CJ.Atrial flutter in the young: A collaborative study of 380 cases. J Am Coll Cardiol 1985; 6:871–878.CrossRefGoogle Scholar
Walsh, EP, Saul, JP, Hulse, E, Rhodes, LA, Hordof, AJ, Mayer, JELock, JE.Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation 1992; 86: 1138–1146.Google Scholar
Case, CL, Gillette, PC, Douglas, DE, Liebermann, RA.Radiofrequency catheter ablation of atrial flutter in postopera tive congenital heart disease. Am Heart J 1994. [In Press]Google Scholar